| Stage | TSLA | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $28.0B | 100.00% | $96.2B | 100.00% | NVDA ×3.43 |
| Gross profit | $5.5B | 19.59% | $72.1B | 74.98% | NVDA +55.4pp |
| Operating income | $718M | 2.56% | $63.7B | 66.24% | NVDA +63.7pp |
| Pre-tax income | $956M | 3.41% | $71.5B | 74.32% | NVDA +70.9pp |
| Net income | $804M | 2.87% | $59.7B | 62.03% | NVDA +59.2pp |
| Stage | TSLA | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $28.0B100.00% | $96.2B100.00% | NVDA ×3.43 |
| Gross profit | 19.59%$5.5B | 74.98%$72.1B | NVDA +55.4pp |
| Operating income | 2.56%$718M | 66.24%$63.7B | NVDA +63.7pp |
| Pre-tax income | 3.41%$956M | 74.32%$71.5B | NVDA +70.9pp |
| Net income | 2.87%$804M | 62.03%$59.7B | NVDA +59.2pp |
No shared counterparties.